Kari Bohlke
Impact in
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
- Immunology and Allergy top 0.5%
- Food Allergy and Anaphylaxis Research
Papers in
- Oncology 22
- Cancer Risks and Factors 9
-
- Venous Thromboembolism Diagnosis and Management 6
- Co-authors
- Gary H. Lyman (12 shared papers)Anna Falanga (5 shared papers)Graham A. Colditz (5 shared papers)Nigel S. Key (4 shared papers)Edward P. Balaban (4 shared papers)Alok A. Khorana (4 shared papers)Ajay K. Kakkar (3 shared papers)Sandra L. Wong (3 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)Journal of Oncology Practice (12 papers)JCO Oncology Practice (4 papers)Obstetrical & Gynecological Survey (2 papers)PEDIATRICS (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Kari Bohlke
71 papers receiving 10.3k citations
Kari Bohlke's Hit Papers
Peers
Comparison fields: 5 of 149
- Internal Medicine 2.0k
- Immunology and Allergy 630
- Oncology 2.3k
- Emergency Medical Services 485
- Reproductive Medicine 588
Countries citing papers authored by Kari Bohlke
This map shows the geographic impact of Kari Bohlke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Bohlke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Bohlke more than expected).
Fields of papers citing papers by Kari Bohlke
This network shows the impact of papers produced by Kari Bohlke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Bohlke. The network helps show where Kari Bohlke may publish in the future.
Co-authors
The 25 scholars most cited alongside Kari Bohlke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update Hit paper breakdown → | 2019 | 1080 |
| 2 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014 Hit paper breakdown → | 2015 | 1057 |
| 3 | Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2015 | 690 |
| 4 | Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2017 | 461 |
| 5 | Management of Cancer Cachexia: ASCO Guideline Hit paper breakdown → | 2020 | 446 |
| 6 | Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline Hit paper breakdown → | 2017 | 437 |
| 7 | Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline Hit paper breakdown → | 2022 | 422 |
| 8 | 2006 | 383 | |
| 9 | Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline Hit paper breakdown → | 2016 | 325 |
| 10 | Antiemetics: ASCO Guideline Update Hit paper breakdown → | 2020 | 298 |
| 11 | Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline Hit paper breakdown → | 2016 | 297 |
| 12 | Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline Hit paper breakdown → | 2018 | 297 |
| 13 | 2019 | 282 | |
| 14 | 2003 | 263 | |
| 15 | 2017 | 261 | |
| 16 | 2004 | 247 | |
| 17 | 2005 | 238 | |
| 18 | 2014 | 208 | |
| 19 | 1998 | 198 | |
| 20 | Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. | 1998 | 195 |
About Kari Bohlke
Kari Bohlke is a scholar working on Oncology, Internal Medicine, Hematology, Public Health, Environmental and Occupational Health and Reproductive Medicine, having authored 75 papers that have together received 10.7k indexed citations. Recurring topics across this work include Cancer Risks and Factors (9 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Nausea and vomiting management (6 papers), Ovarian cancer diagnosis and treatment (4 papers), Vaccine Coverage and Hesitancy (4 papers), Erythropoietin and Anemia Treatment (4 papers), Palliative Care and End-of-Life Issues (4 papers) and Nutritional Studies and Diet (3 papers). The work is most often cited by research in Internal Medicine (2.0k citations), Immunology and Allergy (630 citations), Oncology (2.3k citations), Emergency Medical Services (485 citations) and Reproductive Medicine (588 citations). Kari Bohlke has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Gary H. Lyman, Anna Falanga, Graham A. Colditz, Nigel S. Key, Edward P. Balaban, Alok A. Khorana, Ajay K. Kakkar, Sandra L. Wong, Margaret A. Tempero and Nicole M. Kuderer. Their work appears in journals such as Journal of Clinical Oncology, Journal of Oncology Practice, JCO Oncology Practice, Obstetrical & Gynecological Survey and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.